Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharma Responds To Sandy’s Wrath With Delays

This article was originally published in The Pink Sheet Daily

Executive Summary

As the East Coast braces for the impact of Hurricane Sandy, companies choose the safety of their employees over keeping financial releases on schedule.


Related Content

FDA Faced With A Judgment Call On Hydrocodone Upscheduling
Pharma Only Slightly Winded By Hurricane Sandy
AbbVie Issues Record Debt To Support Independence
Deals Of The Week: Vertex/GSK, Vertex/Janssen, Boehringer Ingelheim/Ensemble
Hurricane Sandy Rains On User Fee Dates, Advisory Committees
Delayed Denial: Cornerstone’s Lixivaptan Gets FDA “Complete Response”
FDA Plows Out: Telecommuting Triumphs As Blizzard Puts A Hole In CDER's Roof


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts